Sulfoximine activators of serotonin receptors
US-2024366542-A1 · Nov 7, 2024 · US
US8962837B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8962837-B2 |
| Application number | US-201113642025-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 15, 2011 |
| Priority date | Apr 19, 2010 |
| Publication date | Feb 24, 2015 |
| Grant date | Feb 24, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to compounds having general formula I characterized in that wherein in particular: R 1 represents one or a plurality of groups such as: trifluoromethyl, halogen such as F, Cl, Br, methyl, nitro. R represents nitrogen T-U represents C═C, V represents N, W represents C═O, R 2 represents Cl or H, R 3 =H and R 4 =Me, A represents wherein n=m=1, X represents —CH 2 — and E represents —CH—, and D represents oxygen, along with the various isomers and mixtures thereof in any proportions, and the pharmaceutically acceptable salts thereof.
Opening claim text (preview).
The invention claimed is: 1. A compound of general formula I wherein R1 is one or more substituents selected from the group consisting of trifluoromethyl, halogen, methyl, and nitro; R is nitrogen; T-U is C═C; V is nitrogen; W is C═O; R2 is Cl or H; R3 is H; and R4 is Me; A is…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.